- Home
- GNLN vs EDSA Comparison
GNLN vs EDSA Comparison
Compare GNLN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- EDSA
- Stock Information
- Founded
- GNLN 2005
- EDSA 2015
- Country
- GNLN United States
- EDSA Canada
- Employees
- GNLN N/A
- EDSA N/A
- Industry
- GNLN Durable Goods
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- GNLN Consumer Discretionary
- EDSA Health Care
- Exchange
- GNLN Nasdaq
- EDSA Nasdaq
- Market Cap
- GNLN 12.9M
- EDSA 13.8M
- IPO Year
- GNLN 2019
- EDSA N/A
- Fundamental
- Price
- GNLN $0.01
- EDSA $2.05
- Analyst Decision
- GNLN
- EDSA Strong Buy
- Analyst Count
- GNLN 0
- EDSA 2
- Target Price
- GNLN N/A
- EDSA $13.00
- AVG Volume (30 Days)
- GNLN 534.9M
- EDSA 33.4K
- Earning Date
- GNLN 08-13-2025
- EDSA 08-08-2025
- Dividend Yield
- GNLN N/A
- EDSA N/A
- EPS Growth
- GNLN N/A
- EDSA N/A
- EPS
- GNLN N/A
- EDSA N/A
- Revenue
- GNLN $9,818,000.00
- EDSA N/A
- Revenue This Year
- GNLN $1,541.21
- EDSA N/A
- Revenue Next Year
- GNLN N/A
- EDSA N/A
- P/E Ratio
- GNLN N/A
- EDSA N/A
- Revenue Growth
- GNLN N/A
- EDSA N/A
- 52 Week Low
- GNLN $0.01
- EDSA $1.55
- 52 Week High
- GNLN $21.80
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- GNLN 28.32
- EDSA 52.89
- Support Level
- GNLN $0.01
- EDSA $1.91
- Resistance Level
- GNLN $0.02
- EDSA $2.14
- Average True Range (ATR)
- GNLN 0.00
- EDSA 0.12
- MACD
- GNLN 0.00
- EDSA 0.02
- Stochastic Oscillator
- GNLN 9.09
- EDSA 64.52
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.